Division of Genome Sciences

Centers of Excellence in Genomic Science

DNA art

Centers of Excellence in Genomic Science Overview

The Human Genome Project (HGP) has produced a wealth of genomic data. The next challenge is to discover and analyze the vast amount of biological information contained within it. The Centers of Excellence in Genomic Science (CEGS) program supports the formation of multi-investigator, interdisciplinary research teams to develop novel and innovative genomic research projects, using the data sets and technologies developed by the HGP.

Each CEGS will conduct highly innovative research designed to develop new concepts, methods, technologies, or ways to analyze data that will substantially advance the state of the art in genomic approaches to the study of a biological problem. Thus, CEGS research will ultimately foster the wider application of comprehensive, high-throughput genomics methods to the study of human biology and disease.

A CEGS will require visionary leadership and strong management. A CEGS will have a single designated Principal Investigator and the leadership may include co-investigators who bring a mix of essential skills.

Each CEGS is also required to have a training component that leverages the strengths of CEGS and its investigators to train the next generation of interdisciplinary scientists, who will bring creative approaches to studying biological problems through a genomic approach. This component of the program includes a specific focus on engaging the talents of individuals from underrepresented minority groups. (See: Minority Action Plan and the Minority Action Plan Portal and Research Tool)

Top of page

Centers of Excellence in Genomic Science Synopsis

View a printable version of this section.PDF file

A successful CEGS must include ALL of the following:

  • A CEGS is highly innovative, being designed to develop new concepts, methods, technologies, or ways to produce or analyze comprehensive data sets, or on a particular genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems and/or significantly furthering the application of genomic knowledge, data and methods towards clinical applications.
  • A CEGS proposes a very substantial advance to addressing a critical issue in genomic science or genomic medicine. Achieving a substantial advance entails risk; this is balanced by the potential for very high payoff and requires an outstanding scientific plan and effective management strategy.
  • A CEGS is a tightly focused project implemented by a multi-investigator, interdisciplinary team working in a highly integrated fashion. Components of the program must be interdependent, not simply related.  Synergy and integration are key.
  • A CEGS will lay out a specific and substantive "product" that can be identified as having been the outcome of CEGS funding.
  • A CEGS will take on challenging aspects of a problem, including ones that have slowed progress in the chosen area of research.
  • A CEGS will increase the pool of professional scientists and engineers able to work in or use genomics, by offering innovative, substantive education and outreach opportunities across appropriate disciplines. It will integrate the training of new and broaden the training of established investigators. Graduate students and postdoctoral fellows, at a minimum, should participate in the research; however, that participation alone is insufficient as an education and outreach effort.

Additional characteristics of a CEGS:

  • A CEGS project may include an ELSI component if it is integrated with and closely related to the main focus or theme of the project.
  • Establishing a CEGS at an institution must add value beyond ongoing activities in genomics at that institution.
  • A CEGS project may propose very substantial improvement in current technology, to increase throughput and decrease cost.
  • A CEGS may choose a cell, organism, tissue, pathway, or disease as a model system in which to develop the concepts or methods, but those concepts or methods must be broadly applicable well beyond the chosen example.

A CEGS is NOT:

  • The obvious next step in a project or field, which could be accomplished by assembling state-of-the-art components and innovating at the level of a typical R01;
  • A program project;
  • Infrastructure for an existing program or department;
  • Primarily for the collection of a dataset in the absence of a novel concept or methodological approach;
  • "Only" outstanding science that fails to meet the criteria required of a CEGS.

Top of page

Centers of Excellence in Genomic Science Program Announcement

  • PAR-14-195: Centers of Excellence in Genomic Science (CEGS) (RM1)
    Letters of Intent Receipt Dates: 30 days before application receipt dates
    Application Receipt Dates: July 2, 2014; May 20, 2015; May 20, 2016

     
    • Notice of Correction to Foreign Components for PAR-14-195 "Centers of Excellence in Genomic Science (CEGS) (RM1)"
      NOT-HG-14-031 [grants.nih.gov]
       
    • Notice of Change to PAR-14-195 Centers of Excellence in Genomic Science (CEGS) (RM1)
      NOT-HG-14-032 [grants.nih.gov]

Top of page

Centers of Excellence in Genomic Science Awarded Grants Information

CEGS Awards Abstracts
CEGS Awards News Releases

For more information about NHGRI funding opportunities, funding history, and application and review, visit our Grants pages.

Centers of Excellence in Genomic Science Staff

Jeff Schloss, Ph.D.
E-mail: schlossj@mail.nih.gov

Address
National Human Genome Research Institute
National Institutes of Health
5635 Fishers Lane
Suite 4076, MSC 9305
Bethesda, MD 20892-9305

Phone: (301) 496-7531
Fax: (301) 480-2770

To view the PDF on this page, you will need Adobe Acrobat Reader. Download Adobe Acrobat Reader

Top of page

Last Updated: October 28, 2014